143 related articles for article (PubMed ID: 37853346)
1. Comparative age-period-cohort analysis.
Rosenberg PS; Miranda-Filho A; Whiteman DC
BMC Med Res Methodol; 2023 Oct; 23(1):238. PubMed ID: 37853346
[TBL] [Abstract][Full Text] [Related]
2. Advances in statistical methods for cancer surveillance research: an age-period-cohort perspective.
Rosenberg PS; Miranda-Filho A
Front Oncol; 2023; 13():1332429. PubMed ID: 38406174
[TBL] [Abstract][Full Text] [Related]
3. Plasma Cell Myeloma - 20-Year Comparative Survival and Mortality of Three Plasma Cell Myeloma ICD-O-3 Oncologic Phenotypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 111,041 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).
Milano AF
J Insur Med; 2018; 47(4):203-211. PubMed ID: 30668210
[TBL] [Abstract][Full Text] [Related]
4. Non-Hodgkin Lymphoma - Nodal and Extranodal: 20-Year Comparative Mortality, Survival & Biologic Behavior Analysis by Age, Sex, Race, Stage, Cell Morphology/Histology, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 384,651 Total NHL Cases Including 261,144 Nodal and 123,507 Extranodal Cases for Diagnosis Years 1975-2016: (SEER*Stat 8.3.6).
Milano AF
J Insur Med; 2023 Jul; 50(1):1-35. PubMed ID: 37725503
[TBL] [Abstract][Full Text] [Related]
5. Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study.
Clegg LX; Reichman ME; Miller BA; Hankey BF; Singh GK; Lin YD; Goodman MT; Lynch CF; Schwartz SM; Chen VW; Bernstein L; Gomez SL; Graff JJ; Lin CC; Johnson NJ; Edwards BK
Cancer Causes Control; 2009 May; 20(4):417-35. PubMed ID: 19002764
[TBL] [Abstract][Full Text] [Related]
6. 20-Year Comparative Survival and Mortality of Cancer of the Stomach by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration & Selected ICD-O-3 Oncologic Phenotypes:
Milano AF
J Insur Med; 2019; 48(1):5-23. PubMed ID: 31609640
[No Abstract] [Full Text] [Related]
7. Racial/ethnic disparities in hepatocellular carcinoma incidence and mortality rates in the United States, 1992-2018.
Alvarez CS; Petrick JL; Parisi D; McMahon BJ; Graubard BI; McGlynn KA
Hepatology; 2022 Sep; 76(3):589-598. PubMed ID: 35124828
[TBL] [Abstract][Full Text] [Related]
8. Decreasing Incidence of Estrogen Receptor-Negative Breast Cancer in the United States: Trends by Race and Region.
Davis Lynn BC; Chernyavskiy P; Gierach GL; Rosenberg PS
J Natl Cancer Inst; 2022 Feb; 114(2):263-270. PubMed ID: 34508608
[TBL] [Abstract][Full Text] [Related]
9. A new age-period-cohort model for cancer surveillance research.
Rosenberg PS
Stat Methods Med Res; 2019; 28(10-11):3363-3391. PubMed ID: 30306829
[TBL] [Abstract][Full Text] [Related]
10. A unified approach for assessing heterogeneity in age-period-cohort model parameters using random effects.
Chernyavskiy P; Little MP; Rosenberg PS
Stat Methods Med Res; 2019 Jan; 28(1):20-34. PubMed ID: 28589750
[TBL] [Abstract][Full Text] [Related]
11. Correlated Poisson models for age-period-cohort analysis.
Chernyavskiy P; Little MP; Rosenberg PS
Stat Med; 2018 Feb; 37(3):405-424. PubMed ID: 28980325
[TBL] [Abstract][Full Text] [Related]
12. Breast Cancer: 20-Year Comparative Mortality and Survival Analysis by Age, Sex, Race/Ethnicity, Stage, Grade, Disease Duration, Selected ICD-O-3 Oncophenotypes, and Cohort Entry Time-Period.
Milano AF
J Insur Med; 2023 Jul; 50(2):80-122. PubMed ID: 38358929
[TBL] [Abstract][Full Text] [Related]
13. Changes in Age Distribution of Obesity-Associated Cancers.
Koroukian SM; Dong W; Berger NA
JAMA Netw Open; 2019 Aug; 2(8):e199261. PubMed ID: 31411715
[TBL] [Abstract][Full Text] [Related]
14. Association Between Race/Ethnicity and Survival of Melanoma Patients in the United States Over 3 Decades: A Secondary Analysis of SEER Data.
Ward-Peterson M; Acuña JM; Alkhalifah MK; Nasiri AM; Al-Akeel ES; Alkhaldi TM; Dawari SA; Aldaham SA
Medicine (Baltimore); 2016 Apr; 95(17):e3315. PubMed ID: 27124020
[TBL] [Abstract][Full Text] [Related]
15. Rates and trends in stage-specific prostate cancer incidence by age and race/ethnicity, 2000-2017.
Cao Y; Zhang W; Li Y; Fu J; Li H; Li X; Gao X; Zhang K; Liu S
Prostate; 2021 Oct; 81(14):1071-1077. PubMed ID: 34320230
[TBL] [Abstract][Full Text] [Related]
16. Age-period-cohort analysis of renal cell carcinoma in United States adults.
Tyson MD; Humphreys MR; Parker AS; Thiel DD; Joseph RW; Andrews PE; Castle EP
Urology; 2013 Jul; 82(1):43-7. PubMed ID: 23706585
[TBL] [Abstract][Full Text] [Related]
17. Trends in cause of death among patients with multiple myeloma in Puerto Rico and the United States SEER population, 1987-2013.
Castañeda-Avila MA; Ortiz-Ortiz KJ; Torres-Cintrón CR; Birmann BM; Epstein MM
Int J Cancer; 2020 Jan; 146(1):35-43. PubMed ID: 30802944
[TBL] [Abstract][Full Text] [Related]
18. Age-Specific Incidence of Melanoma in the United States.
Paulson KG; Gupta D; Kim TS; Veatch JR; Byrd DR; Bhatia S; Wojcik K; Chapuis AG; Thompson JA; Madeleine MM; Gardner JM
JAMA Dermatol; 2020 Jan; 156(1):57-64. PubMed ID: 31721989
[TBL] [Abstract][Full Text] [Related]
19. Early- and late-onset breast cancer types among women in the United States and Japan.
Matsuno RK; Anderson WF; Yamamoto S; Tsukuma H; Pfeiffer RM; Kobayashi K; Devesa SS; Levine PH
Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1437-42. PubMed ID: 17627009
[TBL] [Abstract][Full Text] [Related]
20. Annual Report to the Nation on the Status of Cancer, part I: National cancer statistics.
Cronin KA; Lake AJ; Scott S; Sherman RL; Noone AM; Howlader N; Henley SJ; Anderson RN; Firth AU; Ma J; Kohler BA; Jemal A
Cancer; 2018 Jul; 124(13):2785-2800. PubMed ID: 29786848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
